The state’s Phase Finder tool is no longer needed to check vaccine eligibility as of Monday – KIRO 7 News Seattle
Strongbridge Biopharma plc presents detailed results of the RECORLEV® phase 3 LOGIC study (levocetoconazole) for the treatment of endogenous Cushing’s syndrome at the Endocrine Society’s 2021 annual meeting (ENDO)
COVID in Pennsylvania: the state ranks second in the country in vaccination per capita last week; when Phase 1B could start | Pa. Map of the COVID vaccine (18/03/21)